Home  /  Resource Library  /  Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line Bruton tyrosine kinase inhibitors among elderly patients >65 years in chronic lymphocytic leukemia

Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line Bruton tyrosine kinase inhibitors among elderly patients >65 years in chronic lymphocytic leukemia

Real world study examined treatment patterns in patients with CLL.